2017
DOI: 10.1001/jamapediatrics.2017.2896
|View full text |Cite
|
Sign up to set email alerts
|

Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths

Abstract: IMPORTANCE Antidepressants are one of the most commonly prescribed classes of psychotropic medications among US youths. For adults, there is emerging evidence on the increased risk of type 2 diabetes in association with antidepressant use. However, little is known about the antidepressant treatment-emergent risk of type 2 diabetes among youths.OBJECTIVE To assess the association between antidepressant use and the risk of incident type 2 diabetes in youths by antidepressant subclass and according to duration of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
34
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 44 publications
2
34
0
1
Order By: Relevance
“…However, among sexual minority youth, minority stress has been shown to be associated with increased risk for depression, a known risk factor for diabetes. 34 Both long-term use of certain classes of antidepressant medications 35 and symptoms of depression have also been linked to greater type 2 diabetes prevalence among adolescents. 34,36 While our study was strengthened by a national sample compris- identity detected across 20 variables in YRBS.…”
Section: Discussionmentioning
confidence: 99%
“…However, among sexual minority youth, minority stress has been shown to be associated with increased risk for depression, a known risk factor for diabetes. 34 Both long-term use of certain classes of antidepressant medications 35 and symptoms of depression have also been linked to greater type 2 diabetes prevalence among adolescents. 34,36 While our study was strengthened by a national sample compris- identity detected across 20 variables in YRBS.…”
Section: Discussionmentioning
confidence: 99%
“…Despite expanded use, controversy plagues the benefit-risk discourse on AD use for youth. Questions persist regarding AD efficacy (4), the 2004 FDA boxed warning and safety concerns for suicidality (5), new questions about long-term use with the risk of weight gain and metabolic disorders (6) and prominent concerns about difficulty to discontinue ADs in long-term users due to a withdrawal syndrome (7). Added to these concerns is the fact that pediatric AD use is largely off-label, that is without adequate evidence that benefits outweigh risks either because of age or the diagnosis and indication selected by the treating physician (8).…”
Section: Introductionmentioning
confidence: 99%
“…A common approach to this limitation is to consider proxies, which capture the most severe cases (e.g., dementia, cerebrovascular disease, renal or hepatic failure), and then compute a confounder summary score such as the DRS, which can help in controlling for unmeasured confounders . This approach has been used in several studies conducted on U.S. claims databases such as Medicaid, although we cannot fully exclude residual confounding in risk estimation due to unmeasured confounders. Another limitation is that, in France, coding instructions, which require information about events that lead to hospitalizations (e.g., trauma) but not about their etiology (e.g., falls), guide choice of hospital discharge diagnoses.…”
Section: Discussionmentioning
confidence: 99%